Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px
Organisation › Details

Paion (Group)

PAION is a biopharmaceutical company headquartered in Aachen, Germany and has a second site in Cambridge, UK. The company is specialized in developing and commercializing innovative drugs for the hospital-based treatment in indications for which there is a substantial unmet medical need. PAION has a ´Search & Develop´ business model, which is based on its core expertise in drug development. Where appropriate, particularly during the late stages of the clinical development, PAION seeks to collaborate with experienced partners. *

 

Period Start 2000-01-01 established
Products Industry pharmaceutical
  Industry 2 CNS drug
Persons Person Söhngen, Wolfgang (Paion 200603 CEO)
  Person 2 Omari, Abdelghani (Paion 201409– CFO joined 200810 as VP Finance before KPMG Cologne)
     
Region Region Aachen
  Country Germany
  Street 10–12 Martinistr.
  City 52062 Aachen
  Tel +49-241-4453-0
    Address record changed: 2018-07-24
     
Basic data Employees B: 11 to 50 (2012-12-31)
  Currency EUR
  Annual sales 4,228,000 (revenues, consolidated (2013) 2013-12-31)
  Profit -2,212,000 (2013-12-31)
  Cash 40,500,000 (2015-09-30)
     
    * Document for �About Section�: Paion AG. (12/19/11). "Press Release: Paion Announces Restructuring. Significant Cost Reduction Due to Restructuring of the Company". Aachen.
     
   
Record changed: 2018-10-31

Advertisement

Picture [iito] – Putting Information into Context 600x60px

More documents for Paion (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco January DIC 600x60px




» top